VEO Ophthalmics Launches CUSTOMFLEX® ARTIFICIALIRIS in the U.S.
/Ophthalmic surgeons and their patients now have access to the first FDA-approved iris prosthesis.
CINCINNATI, Ohio – September 27, 2018 – VEO Ophthalmics, LLC, today announced the launch of the CUSTOMFLEX® ARTIFICIALIRIS, the first iris prosthesis available in the United States…
Read More

